Hawthorne Effect operates a tech-driven platform, the Hawthorne Cloud, that decentralizes clinical trials and pairs assessments with a network of trained medical professionals called Hawthorne Heroes. Its service model delivers complete assessments whenever, wherever and however trials and patients require, and the company can run trials as a single virtual site. Since launching in 2015, the solution has been used across more than 50 clinical trials and the company is actively engaged with more than 260 clinical sites. Led by founder and CEO Jodi Akin, Hawthorne Effect aims to alleviate key issues related to patient recruitment and retention. The company raised $20M in a Series A and intends to use the funds to accelerate growth and scale operations. It is based in San Francisco, CA.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2021